
Keywords: HwI; haemophilia with inhibitors; TTE; time-to-event; RTTE; repeated time-to-event; FVIII; factor VIII; FIX; factor IX; rFVIIa; recombinant activated factor VII; rFVIII; recombinant FVIII; FIX; recombinant factor IX; ABR; annualized bleeding rate; Haemoph